|Bid||43.17 x 1000|
|Ask||50.88 x 1000|
|Day's Range||41.41 - 44.00|
|52 Week Range||33.80 - 56.16|
|Beta (5Y Monthly)||0.62|
|PE Ratio (TTM)||49.71|
|Earnings Date||Mar 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||48.00|
Today we will run through one way of estimating the intrinsic value of Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX ) by...
EGRX earnings call for the period ending December 31, 2020.
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 323.26% and -0.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?